SCHEMBL9206531

SCHEMBL9206531

CC1CN(Nc2ccncc2F)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.37
NOTUM Q6P988 1/20 0.37
TGFBR1 P36897 5/20 0.35
TGFBR2 P37173 4/20 0.35
CACNA1G O43497 2/20 0.34
CACNA1H O95180 2/20 0.34
CACNA1I Q9P0X4 2/20 0.34
PIM2 Q9P1W9 2/20 0.33
ROCK2 O75116 1/20 0.33
PRKG1 Q13976 1/20 0.33
CFD P00746 1/20 0.32
SLC6A2 P23975 3/20 0.32
SLC6A4 P31645 3/20 0.32
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9206437 0.90 ROCK1 (0.37) ROCK1NOTUMCACNA1GCACNA1HCACNA1I
SCHEMBL8860185 0.73 MEN1 (0.34) TGFBR1TGFBR2CACNA1GCACNA1HCACNA1I
SCHEMBL9311407 0.72 HTR2C (0.40) LMNASMN1; SMN2
SCHEMBL14218868 0.69 NOTUM (0.50) ROCK1NOTUMSLC6A2SLC6A4SMN1; SMN2
SCHEMBL13663906 0.68 BCHE (0.37) ROCK1NOTUMCACNA1GCACNA1HCACNA1I
SCHEMBL7480165 0.66 TGFBR1 (0.35) TGFBR1TGFBR2CFDLMNA
Hydrochloric Acid SCHEMBL7484530 0.65 TGFBR1 (0.34) TGFBR1TGFBR2CFDLMNA
SCHEMBL8860096 0.65 HPGD (0.37) NOTUMTGFBR1TGFBR2CFD
SCHEMBL7608055 0.65 TGFBR1 (0.38) TGFBR1TGFBR2
SCHEMBL28298834 0.63 NOTUM (0.55) ROCK1NOTUMSLC6A2SLC6A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179821-B2 Method of treating of demyelinating diseases or conditions AVENTIS PHARMACEUTICALS INC. (US) 2007-02-20 US disclosed
EP-0415103-B1 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-02-01 EP disclosed
US-5296488-A Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-03-22 US disclosed
US-5179099-A Analgesics HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-01-12 US disclosed
EP-0415103-A1 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-03-06 EP disclosed